Heart risk under the knife: should cancer patients pause their blood pressure meds?

NCT ID NCT06862115

Recruiting now Knowledge-focused Sponsor: Kasr El Aini Hospital Source: ClinicalTrials.gov ↗

First seen Nov 18, 2025 · Last updated May 17, 2026 · Updated 21 times

Summary

This study is testing whether pausing certain blood pressure medications (called RAS inhibitors) before major colorectal cancer surgery changes the risk of heart injury. About 156 adults with high blood pressure who are scheduled for this surgery will be randomly assigned to either stop their medication before surgery or continue it. The main goal is to see if stopping the medication is just as safe as continuing it, measured by heart damage markers in the blood 48 hours after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIOPERATIVE/POSTOPERATIVE COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cairo university hospitals
RECRUITING

Cairo, Egypt

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR MYOCARDIUM; INJURY PERIOPERATIVE/POSTOPERATIVE COMPLICATIONS